These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9855682)

  • 1. Interleukin-2 at different concentrations induces the growth of selective lymphoid cells.
    Capelli E; Nano R; Civallero M; Cerletti M; Cremaschi P; Nascimbene C; Barni S
    Int J Mol Med; 1998 Aug; 2(2):155-159. PubMed ID: 9855682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
    Stewart JA; Belinson JL; Moore AL; Dorighi JA; Grant BW; Haugh LD; Roberts JD; Albertini RJ; Branda RF
    Cancer Res; 1990 Oct; 50(19):6302-10. PubMed ID: 2205379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.
    Warner SJ; Auger KR; Libby P
    J Immunol; 1987 Sep; 139(6):1911-7. PubMed ID: 3497983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
    London L; Perussia B; Trinchieri G
    J Immunol; 1986 Dec; 137(12):3845-54. PubMed ID: 3491151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
    Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
    J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
    Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
    J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
    Defrance T; Vanbervliet B; Aubry JP; Banchereau J
    J Exp Med; 1988 Oct; 168(4):1321-37. PubMed ID: 3262709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LFA-1/ICAM-1 in interleukin-2-stimulated lymphocyte proliferation.
    Vyth-Dreese FA; Dellemijn TA; Frijhoff A; van Kooyk Y; Figdor CG
    Eur J Immunol; 1993 Dec; 23(12):3292-9. PubMed ID: 7903074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome wide expression profiling of human peripheral blood mononuclear cells stimulated with BAY 50-4798, a novel T cell selective interleukin-2 analog.
    Steppan S; Kupfer K; Mayer A; Evans M; Yamasaki G; Greve JM; Eckart MR; Cassell DJ
    J Immunother; 2007; 30(2):150-68. PubMed ID: 17471163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
    Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats.
    Schotanus K; Tilders FJ; Berkenbosch F
    Endocrinology; 1993 Dec; 133(6):2461-8. PubMed ID: 8243265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D; Cohen BB; Steel CM
    Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of high-affinity IL-4 receptors on murine tumour infiltrating lymphocytes and their up-regulation by IL-2.
    Puri RK; Finbloom DS; Leland P; Mostowski H; Siegel JP
    Immunology; 1990 Aug; 70(4):492-7. PubMed ID: 2203676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma.
    del Olmo M; Alonso-Varona A; Castro B; Bilbao P; Palomares T
    Cancer Immunol Immunother; 2006 Aug; 55(8):948-57. PubMed ID: 16220324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro.
    Gibbons R; Martinez O; Matli M; Heinzel F; Bernstein M; Warren R
    Lymphokine Res; 1990; 9(3):283-93. PubMed ID: 2118969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones.
    Takeda S; Gillis S; Palacios R
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1634-8. PubMed ID: 2784210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.